The Latest Cardiac and Vascular News
TOKYO–(BUSINESS WIRE)–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today announced it has entered into agreement with ITOCHU CHEMICAL FRONTIER Corporation (headquartered in Minato-ku, Tokyo; President & CEO Tsutomu Miyazaki, hereinafter ICF) to form a financial business partnership. In accordance […]
Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to improving the lives of people with heart failure and developer of the innovative CCM™ therapy delivered by the Optimizer® Smart System, today announced the appointment of Ishu Rao, […]
46% Q4 revenue growth; 51% full year growth BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the fourth quarter and 12 months ended December 31, 2019. “We’re pleased to close out another year of compelling […]
Initiated ENHANCE-IT study of MAT9001 against Vascepa®. Topline data expected Q4 2020 Initiated efficacy phase of NIH-funded EnACT study of MAT2203 in cryptococcal meningitis Q1 2020 Management to host conference call today, Monday, March 9th, at 8:00 a.m. ET BEDMINSTER, N.J., March 09, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), […]
SUNNYVALE, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the […]
– Topline data from Phase 3 NODE-301 trial of etripamil in patients with PSVT expected this month – MONTREAL and CHARLOTTE, N.C., March 6, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the fourth quarter and year ended December 31, 2019 and […]
CLBS16 ESCaPE-CMD data presented at American Heart Association 2019 Scientific Sessions demonstrated highly statistically significant improvement in coronary flow reserve and angina symptoms CLBS12 registration eligible trial in Japan targeted to complete enrollment in 1H2020; Data to date continues to corroborate previously published positive results CLBS14 is poised to commence […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of an inducement equity award to a newly hired employee (the “Awardee”). The award was approved by the Company’s Compensation Committee, which is comprised of independent directors, on […]
TORONTO, March 5, 2020 /CNW/ – Baylis Medical is honoured to be recognized as one of Canada’s Best Managed Companies for the third consecutive year. The prestigious award program, which is run by Deloitte, recognizes Canadian companies that invest in technology and sustainable practices, have strategic development processes centered around their core strengths and are committed […]
KIRKLAND, Wash., March 5, 2020 /PRNewswire/ — Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the hiring of Gretchen Gary as Vice President of Global Therapy Development. Ms. Gary brings more than 17 years of structural heart sales, […]
